Skip to main content
. Author manuscript; available in PMC: 2013 Jan 29.
Published in final edited form as: Cancer Biomark. 2011;11(1):1–14. doi: 10.3233/CBM-2012-0260

Table 5.

Diagnostic abilities of individual PBMC genetic expression analyses for differentiating early PC from CP patients

AUC 95% CI Estimated Estimated

Gene AUC SE Lower Upper Threshold* Sensitivity*
ANXA3 0.592 0.071 0.452 0.731 < 0.20 0.271
ARG1 0.516 0.071 0.376 0.656 > 14.67 0.205
CA5B 0.700 0.066 0.572 0.829 ≤ 1.43 0.479
F5 0.678 0.067 0.547 0.808 ≤ 9.99 0.617
SSBP2 0.685 0.067 0.554 0.817 ≤ 0.17 0.479
TBC1D8 0.537 0.074 0.391 0.682 < 0.23 0.167
MUC1 0.536 0.072 0.394 0.677 < 0.024 0.208
MUC16 0.537 0.072 0.397 0.678 < 0.28 0.261
NGAL 0.557 0.071 0.419 0.696 < 9.25 0.333
MIC1 0.640 0.069 0.504 0.776 ≤ 12.82 0.37

AUC, Area Under the Curve; SE, Standard Error; CI, Confidence Interval;

*

All thresholds and sensitivities were estimated using a fixed specificity of 0.80.